Cas no 1805097-59-9 (4-Amino-2-bromo-5-(bromomethyl)pyridine)
4-Amino-2-bromo-5-(bromomethyl)pyridine Chemical and Physical Properties
Names and Identifiers
-
- 4-Amino-2-bromo-5-(bromomethyl)pyridine
-
- Inchi: 1S/C6H6Br2N2/c7-2-4-3-10-6(8)1-5(4)9/h1,3H,2H2,(H2,9,10)
- InChI Key: QEUBRAGJFXCGGJ-UHFFFAOYSA-N
- SMILES: BrCC1C=NC(=CC=1N)Br
Computed Properties
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 10
- Rotatable Bond Count: 1
- Complexity: 110
- XLogP3: 1.8
- Topological Polar Surface Area: 38.9
4-Amino-2-bromo-5-(bromomethyl)pyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A029016951-250mg |
4-Amino-2-bromo-5-(bromomethyl)pyridine |
1805097-59-9 | 95% | 250mg |
$999.60 | 2022-04-01 | |
| Alichem | A029016951-500mg |
4-Amino-2-bromo-5-(bromomethyl)pyridine |
1805097-59-9 | 95% | 500mg |
$1,718.70 | 2022-04-01 | |
| Alichem | A029016951-1g |
4-Amino-2-bromo-5-(bromomethyl)pyridine |
1805097-59-9 | 95% | 1g |
$2,866.05 | 2022-04-01 |
4-Amino-2-bromo-5-(bromomethyl)pyridine Related Literature
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
Additional information on 4-Amino-2-bromo-5-(bromomethyl)pyridine
Introduction to 4-Amino-2-bromo-5-(bromomethyl)pyridine (CAS No. 1805097-59-9)
4-Amino-2-bromo-5-(bromomethyl)pyridine, identified by the Chemical Abstracts Service Number (CAS No.) 1805097-59-9, is a significant intermediate in modern pharmaceutical and agrochemical research. This compound belongs to the pyridine class of heterocyclic aromatic compounds, characterized by a nitrogen atom embedded within a six-membered ring structure. The presence of multiple functional groups—specifically an amino group, two bromine atoms, and a bromomethyl substituent—makes it a versatile building block for synthesizing more complex molecules.
The structural features of 4-amino-2-bromo-5-(bromomethyl)pyridine enable its utility in various synthetic pathways. The amino group (-NH?) provides a nucleophilic site for further functionalization, while the bromine atoms at the 2-position and 5-position introduce reactivity suitable for cross-coupling reactions such as Suzuki-Miyaura, Stille, or Buchwald-Hartwig couplings. Additionally, the bromomethyl group (-CH?Br) serves as a handle for introducing aliphatic side chains or other functional moieties through nucleophilic substitution reactions.
In recent years, 4-amino-2-bromo-5-(bromomethyl)pyridine has garnered attention in the development of novel pharmaceutical agents. Its pyridine core is a common motif in bioactive molecules, with derivatives exhibiting diverse biological activities. For instance, studies have explored its potential in designing kinase inhibitors, which are crucial in targeted cancer therapies. The combination of amino and bromomethyl functionalities allows for precise tuning of molecular properties, enabling optimization of binding affinity and selectivity against therapeutic targets.
One notable application of 4-amino-2-bromo-5-(bromomethyl)pyridine is in the synthesis of small-molecule inhibitors targeting protein-protein interactions (PPIs). PPIs play pivotal roles in numerous cellular processes, making them attractive drug targets. However, their large surface areas and transient interactions pose significant challenges for inhibitor design. The structural versatility of this compound allows medicinal chemists to develop tailored inhibitors by appending specific pharmacophores while maintaining robust binding interactions. Recent advances in fragment-based drug design have leveraged derivatives of 4-amino-2-bromo-5-(bromomethyl)pyridine to identify lead compounds with high efficacy against PPIs.
The agrochemical industry has also benefited from the utility of 4-amino-2-bromo-5-(bromomethyl)pyridine as a precursor for developing novel pesticides and herbicides. Pyridine-based compounds are well-documented for their pesticidal properties, often acting as growth regulators or neurotoxins in pests. By modifying the substituents on the pyridine ring, researchers can fine-tune the biological activity of these compounds. For example, derivatives featuring halogenated alkyl groups have shown promise in controlling resistant weed species by disrupting essential metabolic pathways.
From a synthetic chemistry perspective, 4-amino-2-bromo-5-(bromomethyl)pyridine exemplifies the importance of multifunctional intermediates in streamlining complex syntheses. Its compatibility with transition-metal-catalyzed reactions makes it an invaluable tool for constructing intricate molecular architectures efficiently. This has been particularly advantageous in parallel synthesis campaigns, where large libraries of derivatives can be generated rapidly to screen for biologically active compounds.
The development of novel synthetic methodologies has further expanded the applications of 4-amino-2-bromo-5-(bromomethyl)pyridine. For instance, recent reports highlight its use in palladium-catalyzed cross-coupling reactions under mild conditions, reducing unwanted side products and improving overall yields. Such advancements are critical for sustainable chemistry practices, aligning with global efforts to minimize waste and energy consumption in pharmaceutical manufacturing.
Future research directions may explore the use of 4-amino-2-bromo-5-(bromomethyl)pyridine in medicinal chemistry through innovative approaches such as computer-assisted drug design (CADD). By integrating machine learning algorithms with experimental data, researchers can predict novel derivatives with enhanced pharmacological profiles more efficiently than traditional methods. This synergy between computational modeling and experimental validation holds great promise for accelerating drug discovery pipelines.
In conclusion,4-amino-2-bromo-5-(bromomethyl)pyridine (CAS No. 1805097-59-9) represents a cornerstone compound in synthetic and medicinal chemistry due to its structural versatility and functional reactivity. Its role in developing next-generation pharmaceuticals and agrochemicals underscores its importance as an intermediate in cutting-edge research. As scientific methodologies continue to evolve,4-amino-2-bromo-5-(bromomethyl)pyridine will undoubtedly remain at the forefront of innovation across multiple disciplines.
1805097-59-9 (4-Amino-2-bromo-5-(bromomethyl)pyridine) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)